Literature DB >> 1728357

Characterization of 21 newly established esophageal cancer cell lines.

Y Shimada1, M Imamura, T Wagata, N Yamaguchi, T Tobe.   

Abstract

Twenty-one esophageal cancer cell lines (KYSE series) have been established from the resected specimens of patients with esophageal cancer. Three lines, KYSE-30, KYSE-50, and KYSE-70, were derived from the implanted tumor of nude mice (initial passage); others were derived from resected specimens. Each cell line was morphologically distinct. Detailed cytogenetic analysis indicated that each cell line was karyotypically unique, and DNA fingerprint analysis showed no cross-contamination among cells. Doubling time ranged from 13.7 to 75.5 hours, and modal chromosome numbers ranged from 46 to 120. Most cell lines grew in monolayer, but two cell lines (KYSE-50 and KYSE-360) grew as floating cell aggregates. No correlation was demonstrated between the establishment of cell lines and cell differentiation. These cell lines are the first reported to be homogeneous and individually unique and may provide a useful model for the study of human esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728357     DOI: 10.1002/1097-0142(19920115)69:2<277::aid-cncr2820690202>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  179 in total

1.  Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.

Authors:  Y Kiyozuka; A Asai; D Yamamoto; H Senzaki; S Yoshioka; H Takahashi; K Hioki; A Tsubura
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

3.  Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.

Authors:  Tetsuo Ito; Fumiaki Sato; Takatsugu Kan; Yulan Cheng; Stefan David; Rachana Agarwal; Bogdan C Paun; Zhe Jin; Alexandru V Olaru; James P Hamilton; Florin M Selaru; Jian Yang; Nobutoshi Matsumura; Kazuharu Shimizu; John M Abraham; Yutaka Shimada; Yuriko Mori; Stephen J Meltzer
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

4.  Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation.

Authors:  Xiao-Feng Lu; En-Min Li; Ze-Peng Du; Jian-Jun Xie; Zhang-Yan Guo; Shu-Ying Gao; Lian-Di Liao; Zhong-Ying Shen; Dong Xie; Li-Yan Xu
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

5.  Genetic landscape of esophageal squamous cell carcinoma.

Authors:  Yi-Bo Gao; Zhao-Li Chen; Jia-Gen Li; Xue-Da Hu; Xue-Jiao Shi; Zeng-Miao Sun; Fan Zhang; Zi-Ran Zhao; Zi-Tong Li; Zi-Yuan Liu; Yu-Da Zhao; Jian Sun; Cheng-Cheng Zhou; Ran Yao; Su-Ya Wang; Pan Wang; Nan Sun; Bai-Hua Zhang; Jing-Si Dong; Yue Yu; Mei Luo; Xiao-Li Feng; Su-Sheng Shi; Fang Zhou; Feng-Wei Tan; Bin Qiu; Ning Li; Kang Shao; Li-Jian Zhang; Lan-Jun Zhang; Qi Xue; Shu-Geng Gao; Jie He
Journal:  Nat Genet       Date:  2014-08-24       Impact factor: 38.330

6.  FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.

Authors:  Xiaoming Zhu; Li Wei; Yangqiu Bai; Sen Wu; Shuangyin Han
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

7.  OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.

Authors:  Honghong Zhou; Yongshuo Liu; Rui Zhu; Fang Ding; Xiufeng Cao; Dongxin Lin; Zhihua Liu
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

8.  Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis.

Authors:  Hai-Wei Xie; Qing-Quan Wu; Bin Zhu; Fang-Jun Chen; Lv Ji; Su-Qing Li; Chun-Mei Wang; Yu-Suo Tong; Lei Tuo; Ming Wu; Zhi-Hua Liu; Jin Lv; Wei-Hong Shi; Xiu-Feng Cao
Journal:  Tumour Biol       Date:  2014-05-09

9.  Induction of Immunogenic Cell Death of Esophageal Squamous Cell Carcinoma by 5-Fluorouracil and Cisplatin.

Authors:  Junya Nishimura; Sota Deguchi; Hiroaki Tanaka; Yoshihito Yamakoshi; Mami Yoshii; Tatsuro Tamura; Takahiro Toyokawa; Shigeru Lee; Kazuya Muguruma; Masaichi Ohira
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma.

Authors:  Kan Kondo; Seiji Yamasaki; Naoya Inoue; Tomoharu Sugie; Naoki Teratani; Takatsugu Kan; Yutaka Shimada
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.